Literature DB >> 7811227

Pancreatic lesions in HIV-infected patients.

F G Brivet1, S H Naveau, G F Lemaigre, J Dormont.   

Abstract

The pancreas is frequently involved during HIV infection, especially by disseminated infections or neoplasms. These lesions are generally asymptomatic and are discovered at autopsy. However, hypoglycaemia secondary to massive pancreatic infiltration by a tumour or tuberculous necrosis may occur. The most important cause of pancreatic dysfunction in HIV-infected patients is a drug toxic effect (intravenous pentamidine, didanosine, zalcitabine). Hypoglycaemia, which may or may not be followed by diabetes, can develop during intravenous pentamidine therapy. In cases with increased serum amylase and/or lipase levels, potentially toxic drugs must be promptly discontinued to avoid major pancreatic involvement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811227     DOI: 10.1016/s0950-351x(05)80306-4

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  3 in total

1.  Biochemical assessment of pancreatic disease in human immunodeficiency virus infected men.

Authors:  M R Hancock; N A Smith; D A Hawkins; B Gazzard; S G Ball
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 2.  Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.

Authors:  J C Adkins; D H Peters; D Faulds
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  Drug interactions with antiviral drugs.

Authors:  A M Taburet; E Singlas
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.